A study showed that the activation of CB1R and CB2R, using their respective agonists, induced apoptosis in colon cancer cells, mediated by the de novo synthesis of ceramide, which acts as a pro-apoptotic second messenger [151]. This evidence concerns the gene CNR1 and colonic neoplasm.